Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Genomic Solutions Inc. (NasdaqNM:GNSL)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Reports
Recent Events
July 31Conference call: Genomic Solutions Inc. Earnings (Q2 2001)
Location
4355 Varsity Drive, Suite E
Ann Arbor, MI 48108
Phone: (734) 975-4800
Fax: (734) 975-4804
Email: info@genomicsolutions.com
Employees (last reported count): 160
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Technology
 ·Industry: Scientific & Technical Instr.
Company Websites
 ·Home Page
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 51%
·Over the last 6 months:
 · 2 insider sells; 227.0K shares
  (1.8% of insider shares)
·Institutional: 34% (69% of float)
(62 institutions)
·Net Inst. Selling: 359.0K shares (+4.58%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Genomic Solutions Inc. designs, develops, manufactures, markets and sells genomic and proteomic instrumentation, software, consumables and services. Unlike many other life sciences companies in the DNA microarray and proteomic markets, the Company offers integrated systems with demonstrated market acceptance. The Company's DNA microarray and proteomic products and systems enable researchers to perform complex, high-volume experiments at lower costs and in less time than with traditional techniques. Customers use the Company's integrated and automated systems to produce microarrays, maintain DNA libraries, quantify gene expression levels and isolate, identify and characterize proteins, thereby facilitating more rapid and less expensive drug discovery. The Company sells its products to pharmaceutical and biotechnology companies, government agencies, universities and private research institutions.
More from Market Guide: Expanded Business Description

Financial Summary
GNSL designs, develops, manufactures, markets and sells instruments, software, consumables and services used to determine the activity level of genes and to isolate, identify and characterize proteins. For the six months ended 6/01, total revenues rose 4% to $8.8 million. Net loss applicable to Common before extraordinary item fell 31% to $8.7 million. Revenues reflect higher sales of consumables and services. Net loss reflects a lower deemed dividend.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Robert Shepler, 44
Chairman
--  --  
Jeffrey Williams, 35
Pres, CEO, Director
$517K$1.4M
Steven Richvalsky, 39
CFO, Exec. VP, Treasurer
270K728K
Gary Kendra, 39
Exec. VP, Sec., Gen. Counsel
--  --  
Michael Kurek, Ph.D., 53
Exec. VP of Sales and Service
214K357K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:GNSLAs of 31-Aug-2001
Price and Volume
52-Week Low
on 6-Apr-2001
$1.75 
Recent Price$2.17 
52-Week High
on 3-Oct-2000
$18.813
Daily Volume (3-month avg)106.1K
Daily Volume (10-day avg)35.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-86.8%
52-Week Change
relative to S&P500
-82.4%
Share-Related Items
Market Capitalization$52.8M
Shares Outstanding24.3M
Float11.9M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$1.65 
Earnings (ttm)-$0.44 
Earnings (mrq)-$0.23 
Sales (ttm)$0.78 
Cash (mrq)$0.98 
Valuation Ratios
Price/Book (mrq)1.31 
Price/EarningsN/A 
Price/Sales (ttm)2.78 
Income Statements
Sales (ttm)$19.4M
EBITDA (ttm)-$8.28M
Income available to common (ttm)-$10.9M
Profitability
Profit Margin (ttm)-41.5%
Operating Margin (ttm)-52.1%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-11.17%
Return on Equity (ttm)-21.95%
Financial Strength
Current Ratio (mrq)4.87 
Debt/Equity (mrq)0.04 
Total Cash (mrq)$23.9M
Short Interest
As of 8-Aug-2001
Shares Short8,000 
Percent of Float0.1%
Shares Short
(Prior Month)
12.0K
Short Ratio0.14 
Daily Volume55.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.